Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,372.00    22.00 (1.63%)
Bid:
1,374.00
Ask:
1,378.00
Spread: 4.00 (0.291%)
Market Cap: £469.73m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Total Voting Rights

13 May 2016 07:00

RNS Number : 1408Y
Craneware plc
13 May 2016
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Total Voting Rights

 

In accordance with the Disclosure and Transparency Rules, Craneware announces that at the date of this notice its issued share capital comprises 26,850,248 ordinary shares of 1p ("Ordinary Shares") each with voting rights.

 

No Ordinary Shares are held in treasury.

 

The total voting rights in the Company is therefore 26,850,248. The voting rights of all of the Ordinary Shares are identical.

 

The figure above may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Craneware, under the Disclosure and Transparency Rules.

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

Hilary Buchanan

 

About Craneware

 

Craneware is the leader in automated value cycle solutions that help US provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRAKBDQBBKBKPD
Date   Source Headline
8th Feb 20087:00 amRNSNotice of Interim Results
11th Jan 20087:01 amRNSTrading Statement
31st Oct 20073:06 pmRNSTotal Voting Rights
9th Oct 20074:24 pmRNSIssue of Equity
20th Sep 200711:29 amRNSHolding(s) in Company
19th Sep 20073:52 pmRNSHolding(s) in Company
17th Sep 20076:28 pmRNSHolding(s) in Company
17th Sep 20076:27 pmRNSHolding(s) in Company
17th Sep 20076:22 pmRNSHolding(s) in Company
13th Sep 20077:02 amRNSTrading on PLUS Markets
13th Sep 20077:01 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.